Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otosclerosis | 4 | 2021 | 4 | 2.540 |
Why?
|
| Otolaryngology | 3 | 2020 | 17 | 2.080 |
Why?
|
| Stapes Surgery | 4 | 2021 | 5 | 1.970 |
Why?
|
| Tracheostomy | 2 | 2020 | 28 | 1.440 |
Why?
|
| Postoperative Complications | 3 | 2021 | 670 | 1.220 |
Why?
|
| Meniere Disease | 2 | 2021 | 2 | 1.000 |
Why?
|
| Otologic Surgical Procedures | 2 | 2021 | 2 | 0.990 |
Why?
|
| Reoperation | 3 | 2021 | 203 | 0.950 |
Why?
|
| Stapes | 2 | 2021 | 3 | 0.820 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2021 | 1 | 0.790 |
Why?
|
| Ossicular Prosthesis | 1 | 2020 | 2 | 0.780 |
Why?
|
| Ossicular Replacement | 1 | 2020 | 2 | 0.780 |
Why?
|
| Hydroxyapatites | 1 | 2020 | 3 | 0.780 |
Why?
|
| Bone Cements | 1 | 2020 | 10 | 0.780 |
Why?
|
| Intensive Care Units | 1 | 2021 | 118 | 0.770 |
Why?
|
| Early Ambulation | 1 | 2020 | 7 | 0.760 |
Why?
|
| Arteries | 1 | 2020 | 60 | 0.750 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 4 | 0.730 |
Why?
|
| Retrospective Studies | 8 | 2021 | 3112 | 0.730 |
Why?
|
| Pediatrics | 1 | 2020 | 132 | 0.650 |
Why?
|
| Nasopharyngeal Diseases | 1 | 2015 | 2 | 0.540 |
Why?
|
| Pituitary Gland | 1 | 2015 | 9 | 0.540 |
Why?
|
| Treatment Outcome | 7 | 2021 | 3101 | 0.540 |
Why?
|
| Choristoma | 1 | 2015 | 17 | 0.530 |
Why?
|
| Risk Assessment | 1 | 2020 | 1306 | 0.500 |
Why?
|
| Humans | 18 | 2021 | 29123 | 0.490 |
Why?
|
| United States | 3 | 2020 | 3632 | 0.290 |
Why?
|
| Parkinson Disease | 2 | 2016 | 68 | 0.260 |
Why?
|
| alpha-Synuclein | 2 | 2014 | 10 | 0.250 |
Why?
|
| Infant | 2 | 2020 | 969 | 0.250 |
Why?
|
| Female | 7 | 2021 | 18173 | 0.250 |
Why?
|
| Hearing Loss | 2 | 2021 | 19 | 0.250 |
Why?
|
| Adolescent | 3 | 2020 | 3255 | 0.250 |
Why?
|
| Child | 2 | 2020 | 2219 | 0.240 |
Why?
|
| Male | 8 | 2021 | 17815 | 0.230 |
Why?
|
| Adult | 5 | 2021 | 8426 | 0.210 |
Why?
|
| Skull Base | 1 | 2021 | 3 | 0.210 |
Why?
|
| Cochlear Implants | 1 | 2021 | 2 | 0.200 |
Why?
|
| Cochlear Implantation | 1 | 2021 | 2 | 0.200 |
Why?
|
| Neuroma, Acoustic | 1 | 2021 | 3 | 0.200 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2021 | 7 | 0.200 |
Why?
|
| Endolymphatic Hydrops | 1 | 2021 | 1 | 0.200 |
Why?
|
| Middle Aged | 5 | 2021 | 10834 | 0.200 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 11 | 0.200 |
Why?
|
| Dust | 1 | 2021 | 1 | 0.200 |
Why?
|
| Tympanoplasty | 1 | 2021 | 1 | 0.200 |
Why?
|
| Mastoid | 1 | 2021 | 2 | 0.200 |
Why?
|
| Ear Canal | 1 | 2021 | 4 | 0.200 |
Why?
|
| Granuloma | 1 | 2021 | 13 | 0.200 |
Why?
|
| Intestine, Small | 1 | 2021 | 34 | 0.200 |
Why?
|
| Microscopy | 1 | 2021 | 27 | 0.200 |
Why?
|
| Transplantation, Heterologous | 1 | 2021 | 121 | 0.190 |
Why?
|
| Otitis Media | 1 | 2020 | 21 | 0.190 |
Why?
|
| Facial Nerve | 1 | 2020 | 3 | 0.190 |
Why?
|
| Hearing | 1 | 2020 | 11 | 0.190 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 64 | 0.190 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 88 | 0.190 |
Why?
|
| Clinical Protocols | 1 | 2020 | 95 | 0.180 |
Why?
|
| Aged | 3 | 2020 | 9492 | 0.170 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 150 | 0.170 |
Why?
|
| Patient Readmission | 1 | 2019 | 105 | 0.170 |
Why?
|
| Length of Stay | 1 | 2020 | 292 | 0.170 |
Why?
|
| Pilot Projects | 1 | 2020 | 469 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2021 | 2021 | 0.160 |
Why?
|
| History, 19th Century | 1 | 2018 | 17 | 0.160 |
Why?
|
| Patient Selection | 1 | 2020 | 257 | 0.160 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 2109 | 0.160 |
Why?
|
| Brain | 2 | 2014 | 930 | 0.150 |
Why?
|
| Paraquat | 1 | 2016 | 1 | 0.150 |
Why?
|
| Societies, Medical | 1 | 2018 | 149 | 0.150 |
Why?
|
| Maneb | 1 | 2016 | 2 | 0.150 |
Why?
|
| Young Adult | 2 | 2020 | 2402 | 0.150 |
Why?
|
| Child, Preschool | 1 | 2020 | 1167 | 0.140 |
Why?
|
| Incidence | 1 | 2019 | 1119 | 0.140 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2016 | 96 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1362 | 0.140 |
Why?
|
| Time Factors | 1 | 2020 | 2001 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2016 | 251 | 0.130 |
Why?
|
| beta-Glucosidase | 1 | 2014 | 2 | 0.130 |
Why?
|
| Cholestenones | 1 | 2014 | 1 | 0.130 |
Why?
|
| Secosteroids | 1 | 2014 | 1 | 0.130 |
Why?
|
| Oximes | 1 | 2014 | 6 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 20 | 0.120 |
Why?
|
| Risk Factors | 1 | 2021 | 3537 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 493 | 0.120 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 3719 | 0.110 |
Why?
|
| Aging | 1 | 2016 | 881 | 0.090 |
Why?
|
| Animals | 4 | 2021 | 7300 | 0.060 |
Why?
|
| Substantia Nigra | 2 | 2014 | 11 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 980 | 0.050 |
Why?
|
| Vestibule, Labyrinth | 1 | 2021 | 1 | 0.050 |
Why?
|
| Hearing Tests | 1 | 2021 | 11 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2021 | 91 | 0.050 |
Why?
|
| Audiometry, Evoked Response | 1 | 2021 | 1 | 0.050 |
Why?
|
| Basilar Membrane | 1 | 2021 | 1 | 0.050 |
Why?
|
| Vertigo | 1 | 2021 | 3 | 0.050 |
Why?
|
| Cholesteatoma | 1 | 2020 | 1 | 0.050 |
Why?
|
| Audiometry | 1 | 2020 | 4 | 0.050 |
Why?
|
| Cost Savings | 1 | 2020 | 32 | 0.050 |
Why?
|
| Acoustic Stimulation | 1 | 2021 | 125 | 0.050 |
Why?
|
| Swine | 1 | 2021 | 201 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 130 | 0.050 |
Why?
|
| Office Visits | 1 | 2020 | 71 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2020 | 72 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 88 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2020 | 370 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 51 | 0.040 |
Why?
|
| Risk | 1 | 2016 | 289 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2016 | 425 | 0.030 |
Why?
|
| Tartrates | 1 | 2014 | 1 | 0.030 |
Why?
|
| Imino Pyranoses | 1 | 2014 | 1 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 74 | 0.030 |
Why?
|
| Parkinsonian Disorders | 1 | 2014 | 9 | 0.030 |
Why?
|
| Dopamine Agonists | 1 | 2014 | 28 | 0.030 |
Why?
|
| Movement Disorders | 1 | 2014 | 25 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2014 | 60 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 249 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 332 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2014 | 514 | 0.030 |
Why?
|
| Motor Activity | 1 | 2014 | 310 | 0.030 |
Why?
|
| Mice | 1 | 2014 | 2371 | 0.020 |
Why?
|